Hims Hers Stumbles Open as Regulatory Damage Hits Outlook
Hims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
Assess which option is safer for your needs—software or hardware wallets—by weighing security risks, accessibility, and practical safeguards.
21,982 articlesHims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A clear, practical look at Bowhead Specialty's Q4 2025 earnings transcript. Learn what the numbers mean, which metric...
As the Fed considers stricter rules for stablecoins, Circle’s USDC stands to gain in trust and adoption. This deep-di...
In a televised address ahead of midterm campaigning, Trump pitched a sweeping SNAP reform as proof of tax-cut gains, ...
New to investing? Learn beginner investment amount recommendations to kick off your portfolio with confidence. We'll ...
Marc Zeller’s audit of Aave Labs has sparked new tensions in the AaveDAO as supporters and critics spar over a $51 mi...
A dividend-focused ETF beats a broad market gain on yield and stability. Invesco’s SPHD offers 4.57% income with lowe...
Ethereum broke above the $2,000 mark, signaling a potential rebound after a tough month. Analysts weigh ethereum pric...
A brief but frightening liquidity scare exposed vulnerabilities in the financial system. Regulators acted fast to con...
SoFi Technologies could be on the verge of a significant rerating as revenue and members keep growing. This guide div...
The Army announces a framework allowing private funds to finance and operate base infrastructure, signaling a major s...